Published in Hospital Business Week, August 5th, 2007
Affiris GmbH, based in Vienna, Austria, announced the start of a phase I clinical trial for its Alzheimer's vaccine, Affitope AD01. The vaccine is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week